Concurrent and Adjuvant Temozolomide for Newly Diagnosed Grade III Gliomas without 1p/19q Co-deletion: A Randomized, Open-Label, Phase 2 Study (KNOG-1101 Study)

PURPOSE: We investigated the efficacy of temozolomide during and after radiotherapy in Korean adults with anaplastic gliomas without 1p/19q co-deletion. MATERIALS AND METHODS: This was a randomized, open-label, phase 2 study and notably the first multicenter trial for Korean grade III glioma patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Kihwan, Kim, Tae Min, Park, Chul-Kee, Chang, Jong Hee, Jung, Tae-Young, Kim, Jin Hee, Nam, Do-Hyun, Kim, Se-Hyuk, Yoo, Heon, Hong, Yong-Kil, Kim, Eun-Young, Lee, Dong-Eun, Joo, Jungnam, Kim, Yu Jung, Choe, Gheeyoung, Choi, Byung Se, Kang, Seok-Gu, Kim, Jeong Hoon, Kim, Chae-Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176949/
https://www.ncbi.nlm.nih.gov/pubmed/31671938
http://dx.doi.org/10.4143/crt.2019.421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7176949/
https://www.ncbi.nlm.nih.gov/pubmed/31671938
http://dx.doi.org/10.4143/crt.2019.421

Ejemplares similares